BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12410095)

  • 1. Scleroderma overlap syndromes.
    Pope JE
    Curr Opin Rheumatol; 2002 Nov; 14(6):704-10. PubMed ID: 12410095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlap syndromes and mixed connective tissue disease.
    Maddison PJ
    Curr Opin Rheumatol; 1991 Dec; 3(6):995-1000. PubMed ID: 1772755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma overlap syndromes.
    Jablonska S; Blaszczyk M
    Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of systemic autoimmune disease with intricate features of systemic sclerosis, lupus, polymyositis and rheumatoid arthritis. Overlap syndrome or mixed connective tissue disease?
    Radulescu D; Pripon S; Ciovicescu F; Constantea NA
    Acta Reumatol Port; 2007; 32(3):292-7. PubMed ID: 17932479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.
    Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M
    Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological hallmarks of systemic sclerosis overlap syndromes.
    Pakozdi A; Nihtyanova S; Moinzadeh P; Ong VH; Black CM; Denton CP
    J Rheumatol; 2011 Nov; 38(11):2406-9. PubMed ID: 21844148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients.
    Vandergheynst F; Ocmant A; Sordet C; Humbel RL; Goetz J; Roufosse F; Cogan E; Sibilia J
    Clin Exp Rheumatol; 2006; 24(2):129-33. PubMed ID: 16762146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients.
    Paradowska-Gorycka A; Stypińska B; Olesińska M; Felis-Giemza A; Mańczak M; Czuszynska Z; Zdrojewski Z; Wojciechowicz J; Jurkowska M
    HLA; 2016 Jan; 87(1):13-8. PubMed ID: 26818120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
    Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
    Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.
    Mahler M; Greidinger EL; Szmyrka M; Kromminga A; Fritzler MJ
    Ann N Y Acad Sci; 2007 Aug; 1109():311-21. PubMed ID: 17785320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap syndromes and mixed connective tissue disease.
    Maddison PJ
    Curr Opin Rheumatol; 1990 Dec; 2(6):967-71. PubMed ID: 2083165
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
    Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
    Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myopathy in scleroderma and in other connective tissue diseases.
    Paik JJ
    Curr Opin Rheumatol; 2016 Nov; 28(6):631-5. PubMed ID: 27548651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to nonhistone nuclear antigens and their clinical significance.
    Nakamura RM; Tan EM
    Hum Pathol; 1983 May; 14(5):392-400. PubMed ID: 6341205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A juvenile case of overlap syndrome of systemic lupus erythematosus and polymyositis, later accompanied by systemic sclerosis with the development of anti-Scl 70 and anti-Ku antibodies.
    Nitta Y; Muramatsu M
    Pediatr Dermatol; 2000; 17(5):381-3. PubMed ID: 11085667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.